ABMYVO
Dead / Abandoned — Abandoned — after publication (as of 17 Sept 2024)
What this means for you
This application is over — abandoned 16 Sept 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98264911
- Mark type
- Stylized text
- Filed
- 10 Nov 2023
- Published for opposition
- 23 Jul 2024
- Abandoned
- 16 Sept 2024
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of mitochondrial diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of liver and kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations for the prevention and treatment of fibrosis
Owner
- Reneo Pharmaceuticals, Inc., Irvine, CA, US
- Reneo Pharmaceuticals, Inc., Irvine, CA, US
Prosecution history
- 20 Nov 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 17 Sept 2024 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 17 Sept 2024 — ABANDONMENT - AFTER PUBLICATION
- 16 Sept 2024 — TEAS EXPRESS ABANDONMENT RECEIVED
- 16 Aug 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 15 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Aug 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Aug 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jul 2024 — PUBLISHED FOR OPPOSITION
- 03 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2024 — ASSIGNED TO EXAMINER
- 13 Dec 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Nov 2023 — NEW APPLICATION ENTERED